Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biogem is an Italy-based biotechnology research organization and GLP-certified preclinical services provider focused on molecular biology, genetics, and translational biomedical research. The organization operates a scientific center in Ariano Irpino and conducts research primarily in oncology and nephrology, while also supporting external pharmaceutical and biotechnology clients through nonclinical R&D services. Its capabilities include in vivo and in vitro toxicity studies, pharmacokinetic and ADME work, xenograft and patient-derived xenograft oncology models, bioanalytics, cell culture, computational biology, and the production of recombinant proteins and monoclonal antibodies. Biogem appears to function more as a research institute/CRO platform than as a traditional drug developer with a disclosed clinical-stage proprietary pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biogem.